Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Europe’s children need medicines designed for them

01.02.2005


Parents of children with rare diseases appealed this week to Europe’s lawmakers to approve proposals for encouraging clinical trials involving children. The call came at a conference in Brussels organised by the European Forum for Good Clinical Practice (EFGCP). Throughout Europe, 15 million children suffer from rare diseases, said Yann Le Cam from the European Organisation for Rare Diseases, yet almost no new medicines are being produced with them in mind. “In drug development, children come last,” he said.



Earlier, the conference had heard from European Commission official Peter Arlett about proposals – currently being considered by the European Parliament and the Council of Ministers – to encourage pharmaceutical companies to produce medicines specifically tested for babies and children.

“Children are not small adults,” said Ysbrand Poortman, Chairman of the European Platform for Patients’ Organisations and Industry. “Their bodies work differently. You can’t just take an adult dose, reduce it in proportion to the child’s size, and expect it do the same job.”


Astonishingly, the conference heard, almost none of the medicines commonly used to treat babies and children have been subjected to rigorous clinical trials designed specifically for the young. “Concerns about conducting trials in children should be balanced by the ethical concerns about giving medicines to a population in which they have not been tested,” said Arlett.

The EFGCP now aims to help Europe’s parliamentarians when they come to approve the proposed regulations next spring. “Of course politicians are wary of putting the words ‘children’ and ‘clinical trials’ in the same sentence. But they have to understand that the parents of sick and dying children are desperate for solutions. Provided that these trials are carried out ethically and under tight controls, only when necessary and with minimum risk, the result will be a major contribution to child health,” said Francis Crawley, Secretary General of the EFGCP

The outcome could also be a major contribution to Europe’s economic health. The US is already nearly 10 years ahead of Europe with this kind of regulation, and any delay risks losing jobs and products across the Atlantic.

Fanny Senez | alfa
Further information:
http://www.efgcp.org

More articles from Health and Medicine:

nachricht New flexible, transparent, wearable biopatch, improves cellular observation, drug delivery
12.11.2018 | Purdue University

nachricht Exosomes 'swarm' to protect against bacteria inhaled through the nose
12.11.2018 | Massachusetts Eye and Ear Infirmary

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: A Leap Into Quantum Technology

Faster and secure data communication: This is the goal of a new joint project involving physicists from the University of Würzburg. The German Federal Ministry of Education and Research funds the project with 14.8 million euro.

In our digital world data security and secure communication are becoming more and more important. Quantum communication is a promising approach to achieve...

Im Focus: Research icebreaker Polarstern begins the Antarctic season

What does it look like below the ice shelf of the calved massive iceberg A68?

On Saturday, 10 November 2018, the research icebreaker Polarstern will leave its homeport of Bremerhaven, bound for Cape Town, South Africa.

Im Focus: Penn engineers develop ultrathin, ultralight 'nanocardboard'

When choosing materials to make something, trade-offs need to be made between a host of properties, such as thickness, stiffness and weight. Depending on the application in question, finding just the right balance is the difference between success and failure

Now, a team of Penn Engineers has demonstrated a new material they call "nanocardboard," an ultrathin equivalent of corrugated paper cardboard. A square...

Im Focus: Coping with errors in the quantum age

Physicists at ETH Zurich demonstrate how errors that occur during the manipulation of quantum system can be monitored and corrected on the fly

The field of quantum computation has seen tremendous progress in recent years. Bit by bit, quantum devices start to challenge conventional computers, at least...

Im Focus: Nanorobots propel through the eye

Scientists developed specially coated nanometer-sized vehicles that can be actively moved through dense tissue like the vitreous of the eye. So far, the transport of nano-vehicles has only been demonstrated in model systems or biological fluids, but not in real tissue. The work was published in the journal Science Advances and constitutes one step further towards nanorobots becoming minimally-invasive tools for precisely delivering medicine to where it is needed.

Researchers of the “Micro, Nano and Molecular Systems” Lab at the Max Planck Institute for Intelligent Systems in Stuttgart, together with an international...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

“3rd Conference on Laser Polishing – LaP 2018” Attracts International Experts and Users

09.11.2018 | Event News

On the brain’s ability to find the right direction

06.11.2018 | Event News

European Space Talks: Weltraumschrott – eine Gefahr für die Gesellschaft?

23.10.2018 | Event News

 
Latest News

In focus: Peptides, the “little brothers and sisters” of proteins

12.11.2018 | Life Sciences

Materials scientist creates fabric alternative to batteries for wearable devices

12.11.2018 | Materials Sciences

A two-atom quantum duet

12.11.2018 | Physics and Astronomy

VideoLinks
Science & Research
Overview of more VideoLinks >>>